» Authors » Jun Ki Hong

Jun Ki Hong

Explore the profile of Jun Ki Hong including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 129
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Seok J, Koh Y, Hong J, Yun S, Kim D, Son H, et al.
Dermatol Surg . 2024 Mar; 50(6):527-533. PMID: 38518110
Background: Despite the widespread use of botulinum toxin (BTX) injection for the treatment of masseter muscle hypertrophy (MMH), there is no standard treatment option. Objective: We report the efficacy and...
2.
Koh D, Lee M, Park Y, Shin J, Kim J, Ryu Y, et al.
Cancer Immunol Res . 2024 Jan; 12(4):491-507. PMID: 38289363
The development of first-generation immune-checkpoint inhibitors targeting PD-1/PD-L1 and CTLA-4 ushered in a new era in anticancer therapy. Although immune-checkpoint blockade therapies have shown clinical success, a substantial number of...
3.
Hong J, Gresham I, Daniel D, Waterhouse A, Neto C
ACS Appl Mater Interfaces . 2023 Nov; 15(48):56433-56441. PMID: 37975828
Tethered-liquid perfluorocarbons (TLPs) are a class of liquid-infused surfaces with the ability to reduce blood clot formation (thrombosis) on blood-contacting medical devices. TLP comprises a tethered perfluorocarbon (TP) infused with...
4.
Yun H, You J, Hong J, Kim D, Lee J, Kang D, et al.
Med Oncol . 2023 Nov; 40(12):348. PMID: 37935810
Colorectal cancer (CRC) is one of the highest mortality rates worldwide, and various studies reported to the occurrence of CRC. In particular, the Wnt/β-catenin pathway is known to be a...
5.
Kim J, Koh D, Lee M, Park Y, Hong S, Shin J, et al.
Cell Death Differ . 2023 Nov; 30(12):2491-2507. PMID: 37926711
Recepteur d'origine nantais (RON, MST1R) is a single-span transmembrane receptor tyrosine kinase (RTK) aberrantly expressed in numerous cancers, including various solid tumors. How naturally occurring splicing isoforms of RON, especially...
6.
Han H, Koh Y, Hong J, Roh Y, Seo S, Park K
J Dermatolog Treat . 2023 Jun; 34(1):2220444. PMID: 37272353
Background: Dupilumab facial redness (DFR) is a side effect of dupilumab treatment that has only been recently reported. We previously reported on two patients with DFR who were successfully treated...
7.
Hong J, Waterhouse A
Arterioscler Thromb Vasc Biol . 2023 Apr; 43(6):797-812. PMID: 37078288
Medical devices form a critical component of health care systems for treating and maintaining patient health. However, devices exposed to blood are prone to blood clotting (thrombosis) and bleeding complications...
8.
Han H, Hong J, Yoo K, Seo S
Ann Dermatol . 2023 Feb; 35(1):56-60. PMID: 36750459
Becker's nevus (BN) is a benign hamartoma that may present as a distressing cosmetic problem. The treatment of BN poses a significant challenge as current therapeutic modalities are suboptimal and...
9.
Han H, Hong J, Park S, Park B, Park K
Ann Dermatol . 2023 Feb; 35(1):23-31. PMID: 36750455
Background: The advent of fractionated picosecond (ps) lasers has provided an opportunity to explore new ways of creating microinjuries in the skin to induce skin rejuvenation. Objective: To compare the...
10.
Park S, Hong J, Hong S, Li K
Ann Dermatol . 2022 Dec; 34(6):482-484. PMID: 36478432
No abstract available.